Keyphrases
Adult Patients
25%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
75%
Allogeneic Transplantation
100%
Anaplastic Large Cell Lymphoma
25%
Angioimmunoblastic T-cell Lymphoma
25%
Baseline Characteristics
25%
Disease Pattern
100%
Donor Source
100%
Haploidentical Hematopoietic Stem Cell Transplantation
75%
Hematopoietic Cell Transplantation
50%
Lymphoma
25%
Marrow
25%
Mature T-cell Lymphoma
100%
Non-relapse Mortality
25%
Overall Survival
25%
Performance Status
25%
Peripheral T-cell Lymphoma
25%
Post-transplantation Cyclophosphamide (PTCy)
25%
Progression-free Survival
25%
Registry Study
25%
Source Characteristics
100%
T Cell Depletion
50%
Unrelated Donor
100%
Unrelated Hematopoietic Stem Cell Transplantation
50%
Medicine and Dentistry
Allograft
100%
Anaplastic Large Cell Lymphoma
10%
Angioimmunoblastic T-Cell Lymphoma
10%
Cell Transplantation
100%
Cyclophosphamide
10%
Diseases
100%
Hematopoietic Cell
100%
Overall Survival
10%
Peripheral T-Cell Lymphoma
10%
Progression Free Survival
10%
T Cell
20%
T-Cell Lymphoma
100%
Immunology and Microbiology
Allograft
100%
Cell Transplantation
100%
Cyclophosphamide
10%
Hematopoietic Cell
100%
Lymphoma Cell
10%
Overall Survival
10%
Peripheral T-Cell Lymphoma Not Otherwise Specified
10%
Progression Free Survival
10%
T Cell
100%
T Cell Depletion
20%